FDA Approved: JARDIANCE — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves JARDIANCE (empagliflozin) as an original application for the treatment of type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

ORIG AP for JARDIANCE (EMPAGLIFLOZIN)